Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
Ashley T. Martino(St. John's University), Roland W. Herzog(Heidelberg University), David A. Ostrov(University of Florida), Arun Srivastava(University of Florida), Christian Hinderer(Children's Hospital of Philadelphia), Katherine A. High(Spark Therapeutics (United States)), Etiena Basner‐Tschakarjan(Children's Hospital of Philadelphia), Jonathan D. Finn(Children's Hospital of Philadelphia), Federico Mingozzi(Spark Therapeutics (United States)), Hildegund C.J. Ertl(The Wistar Institute), David M. Markusic(Pediatrics and Genetics), Shangzhen Zhou(Penn Presbyterian Medical Center), Cox Terhorst(Beth Israel Deaconess Medical Center)
Cited by 160
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Gene therapy comes of age
|Science|2018|1.4k
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
|Nature|1998|942